Stansky Michael P bought TLSI
February 4, 2026 · Form 4 insider transaction
Stansky Michael P bought 92,537 shares of TriSalus Life Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
92,537
Price
$0.00
Total value
N/A
InsiderStansky Michael P
Role—
SecurityDirector Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 4, 2026
Filing dateFebruary 11, 2026
Shares owned after92,537
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this stock option vest in three equal annual installments commencing on February 4, 2027, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.